These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11519169)

  • 1. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
    Yamazoe Y; Nagata K
    Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genetic polymorphisms in drug-metabolizing enzymes].
    Saruwatari J; Nakagawa K; Ishizaki T
    Nihon Rinsho; 2002 Jan; 60(1):58-63. PubMed ID: 11808340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.
    Schwaiblmair M; Behr W; Foerg W; Berghaus T
    Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1547-60. PubMed ID: 22070131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
    Johansson I; Ingelman-Sundberg M
    Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment.
    Brockmöller J; Kirchheiner J; Meisel C; Roots I
    Pharmacogenomics; 2000 May; 1(2):125-51. PubMed ID: 11256586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
    Zhao L; Lou YQ
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes.
    Yoo HD; Lee YB
    Arch Pharm Res; 2011 Nov; 34(11):1817-28. PubMed ID: 22139683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping].
    Johansen PW; Bergan S; Rootwelt H; Kvittingen EA; Rugstad HE
    Tidsskr Nor Laegeforen; 2002 Nov; 122(29):2781-3. PubMed ID: 12523145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
    Mathijssen RH; van Schaik RH
    Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia.
    Pakakasama S; Mukda E; Sasanakul W; Kadegasem P; Udomsubpayakul U; Thithapandha A; Hongeng S
    Am J Hematol; 2005 Jul; 79(3):202-5. PubMed ID: 15981231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cytochrome P450 enzymes in the metabolism of antineoplastic drugs].
    Quiñones S L; Rosero P M; Roco A A; Moreno T I; Sasso A J; Varela F N; Cáceres L D; Saavedra S I
    Rev Med Chil; 2008 Oct; 136(10):1327-35. PubMed ID: 19194632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
    Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics-guided dose modifications of antidepressants.
    Seeringer A; Kirchheiner J
    Clin Lab Med; 2008 Dec; 28(4):619-26. PubMed ID: 19059066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 906 variations among 27 genes encoding cytochrome P450 (CYP) enzymes and aldehyde dehydrogenases (ALDHs) in the Japanese population.
    Saito S; Iida A; Sekine A; Ogawa C; Kawauchi S; Higuchi S; Ohno M; Nakamura Y
    J Hum Genet; 2002; 47(8):419-44. PubMed ID: 12181643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the world of cytochrome P450 enzymes.
    Frye RF
    Mol Interv; 2004 Jun; 4(3):157-62. PubMed ID: 15210869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.